Graphite Bio Inc

NASDAQ:GRPH 12:11:34 PM EDT

8.91

-0.24 (-2.62%)

Graphite Bio Inc Stock, NASDAQ:GRPH

201 Haskins Way, Suite 210, South San Francisco, California 94080

United States of America

Phone: +1.650.484.0886

Number of Employees:

http://www.graphitebio.com

Description

Graphite Bio, Inc. operates as a clinical-stage gene editing company. It focuses on therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo in June 2017 and is headquartered in South San Francisco, CA.